Breast Cancer Clinical Trial
Official title:
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
| Verified date | December 2009 |
| Source | Mind Matters Research LLC |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Global Objective: To improve quality of life and reduce stress for breast cancer survivors.
To address the late-term and long-term effects of breast cancer treatment, as defined by the
Institute of Medicine, including chemo brain, fatigue, sleep deprivation, stress, anxiety,
depression, and PTSD.
Phase II Aims: (1) To demonstrate the clinical efficacy (i.e., improved quality of life,
stress reduction, participant satisfaction with product) of the "Envision the Rhythms of
Life" program and (2) to establish the technical merits of the program's distance-delivery
(videoconferencing hardware and software) and instructional technology (i.e., animations,
graphically enhanced PowerPoint instructional materials, full-color program manuals,
art-as-imagery, and audio-imagery). "Envision the Rhythms of Life" instructs breast cancer
survivors in the practice of individualized, emotionally supportive, and biologically
accurate imagery and consists of 5, 4-hour long, interactive classes and between-class
instructor support.
Instructional Options: Option 1 delivers the program technology (animations, PowerPoint,
manuals, art, audio-art) with instructor and participants in the same room. Option 2 delivers
the program at-a-distance, to a small group of, via videoconferencing software and camera
systems (Alaska and Seattle) to low, moderate or high bandwidth areas. Each option delivers
program three times (total of 45 participants for each option). A website portal provides all
program information and materials.
Design and Method: Program will be delivered to 135 breast cancer survivors who have
completed conventional care (surgery, radiation, IV chemotherapy) for at least six weeks.
Differences in option 1 and 2 outcomes will be compared to each other and to controls;
combined outcomes of option 1 and 2 will be compared to controls; and waitlist control
outcomes will be compared to their extended baseline. Hypothesis: Options 1 and 2 will both
produce significantly better outcomes than waitlist control group.
| Status | Completed |
| Enrollment | 135 |
| Est. completion date | October 11, 2011 |
| Est. primary completion date | September 2010 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Participants must be a community-dwelling member 18 years of age or older. - The participant must be at least 18 because the assessment tools are not validated for use in minors. - Participants should be able to read, write, and speak English. - Participants must have been diagnosed with breast cancer and have completed surgery, which did not include Level III dissection of the axilla. - Participants must obtain verification of diagnosis and treatment from their physician. - Participants must agree to complete assessment instruments and take part in psychophysiological data gathering at baseline, 8 and 17 weeks and to provide required demographic information. - Participants must sign informed consent, stating he/she understands the nature of the research and that he/she wishes to participate in the study. - - Participants must agree to complete the required diaries, graphs and notebooks related to behavior assessment. - Participants must display the ability to understand and respond to the assessment process and must demonstrate they are oriented to person, place, and time. - Participants must agree to fully participate in all five imagery classes and to practice imagery skills for 20 minutes a day for 17 weeks. - Participants must have completed major cancer treatment (i.e., surgery, and/or radiation and/or IV chemotherapy) for six weeks; participant must be visual and hearing capable. - Oral chemotherapy does not preclude participation. Exclusion Criteria: - Participant will be excluded if he/she has a history of uncontrolled epileptic seizures. - The investigators will exclude patients who cannot speak, read and write English. - Patients will be excluded if they are not oriented to place, person, and time. - Participants will be excluded if they have a major psychiatric diagnosis (schizophrenia, bi-polar disorder). - The investigators will exclude patients who received a Level III dissection of the axilla. - Participants will be excluded if they are visually or hearing impaired. - Although imagery can be modified for the visually or hearing impaired, that model is significantly different from an imagery program for the visual and hearing capable. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Gilda's Club Seattle | Seattle | Washington |
| Lead Sponsor | Collaborator |
|---|---|
| Mind Matters Research LLC |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Primary Objective: Measure QOL differences between treatment groups: (delivered live vs videoconferencing) and as compared to the control group and their extended baseline. | Data is gathered at baseline (before intervention) and 8 weeks, and at 17 weeks. | ||
| Secondary | The secondary objective is for the purposes of improving program materials, documenting patient satisfaction, and recording patient experience of imagery. Focus groups, summary reports, and 10-point likert scales, rated from very dissatisfied (1) to very | Data gathered across each week, beginning with first week of intervention, for a period of 17 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |